InCytu’s breakthrough, proprietary, platform technology, Cellarium™, is poised to address many large unmet patient needs and enable many promising technologies. The company is privately held and has secured financing from private and professional investors to fund its progress. InCytu will pursue future funding rounds from individuals and institutions to complete its regulatory and clinical development programs. The Company actively evaluates potential partners who provide strategic and commercialization opportunities as well as synergistic technologies with the ability to progress and expand its development programs. For more information, please contact us at info@incytu.com.